Items where Author is "Gharibdoost, F."

(2022) Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia (R)) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial. ARTHRITIS RESEARCH & THERAPY. ISSN 1478-6354 1478-6362 J9 - ARTHRITIS RES THER

(2022) Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial. Arthritis Research & Therapy. p. 10. ISSN 1478-6354

(2021) Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study. Advances in Therapy. pp. 1290-1300. ISSN 0741-238X

(2021) A Phase IV Study of the Safety and Efficacy of CinnoPar (R) in Iranian Patients with Osteoporosis. Journal of Osteoporosis. ISSN 2090-8059

(2018) Expressions of p53 and PUMA in fibroblasts of systemic sclerosis patients are normal at transcription level. Journal of Cosmetic Dermatology. pp. 549-554. ISSN 1473-2165 (Electronic) 1473-2130 (Linking)

(2016) Comparison of the expression levels of Fas and Apaf-1 genes in systemic sclerosis dermal fibroblasts. Tehran University Medical Journal. pp. 282-288. ISSN 16831764 (ISSN)